Close Menu

NEW YORK (GenomeWeb) – Biocept today announced an agreement to participate in MultiPlan's national primary preferred provider organization and complementary network.

Under the terms of the agreement, patients in MultiPlan's networks will have access to Biocept's liquid biopsy diagnostic services, effective August 1. MultiPlan is a national healthcare organization under contract with almost 900,000 providers, Biocept said in a statement, adding about 68 million consumers access the healthcare cost management firm's networks.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.